| Title |
Milrinone and Homeostasis to Treat Cerebral Vasospasm Associated with Subarachnoid Hemorrhage: The Montreal Neurological Hospital Protocol
|
|---|---|
| Published in |
Neurocritical Care, April 2012
|
| DOI | 10.1007/s12028-012-9701-5 |
| Pubmed ID | |
| Authors |
Marcelo Lannes, Jeanne Teitelbaum, Maria del Pilar Cortés, Mauro Cardoso, Mark Angle |
| Abstract |
For the treatment of cerebral vasospasm, current therapies have focused on increasing blood flow through blood pressure augmentation, hypervolemia, the use of intra-arterial vasodilators, and angioplasty of proximal cerebral vessels. Through a large case series, we present our experience of treating cerebral vasospasm with a protocol based on maintenance of homeostasis (correction of electrolyte and glucose disturbances, prevention and treatment of hyperthermia, replacement of fluid losses), and the use of intravenous milrinone to improve microcirculation (the Montreal Neurological Hospital protocol). Our objective is to describe the use milrinone in our practice and the neurological outcomes associated with this approach. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 2 | 1% |
| Brazil | 2 | 1% |
| Netherlands | 1 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 171 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 29 | 16% |
| Researcher | 23 | 13% |
| Student > Postgraduate | 23 | 13% |
| Professor > Associate Professor | 14 | 8% |
| Student > Master | 14 | 8% |
| Other | 44 | 25% |
| Unknown | 31 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 109 | 61% |
| Neuroscience | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Nursing and Health Professions | 3 | 2% |
| Agricultural and Biological Sciences | 3 | 2% |
| Other | 9 | 5% |
| Unknown | 38 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2021.
All research outputs
#14,917,751
of 25,388,837 outputs
Outputs from Neurocritical Care
#1,062
of 1,740 outputs
Outputs of similar age
#98,545
of 173,620 outputs
Outputs of similar age from Neurocritical Care
#6
of 12 outputs
Altmetric has tracked 25,388,837 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,740 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,620 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.